Artwork

Content provided by Chris Shulgan and Medcan CEO Shaun Francis. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Chris Shulgan and Medcan CEO Shaun Francis or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Liquid Biopsy: The Future of Early Cancer Detection

34:24
 
Share
 

Manage episode 332695164 series 2779508
Content provided by Chris Shulgan and Medcan CEO Shaun Francis. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Chris Shulgan and Medcan CEO Shaun Francis or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

“Liquid biopsy” is a form of cancer screening that detects biomarkers in the blood with a simple draw. Research indicates that it could help to detect disease months or even years before other, more expensive and more invasive forms of screening, helping to save lives. So how exactly does it work? Is it better at detecting some cancers compared to others? And how can it help oncologists treat already diagnosed cases? Medcan’s director of clinical innovation, Allison Hazell, investigates with the help of Dr. Lewis Roberts, director of the Mayo Clinic’s Hepatobiliary Cancer Lab.

Check out the episode webpage for links and more info.

  continue reading

104 episodes

Artwork
iconShare
 
Manage episode 332695164 series 2779508
Content provided by Chris Shulgan and Medcan CEO Shaun Francis. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Chris Shulgan and Medcan CEO Shaun Francis or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

“Liquid biopsy” is a form of cancer screening that detects biomarkers in the blood with a simple draw. Research indicates that it could help to detect disease months or even years before other, more expensive and more invasive forms of screening, helping to save lives. So how exactly does it work? Is it better at detecting some cancers compared to others? And how can it help oncologists treat already diagnosed cases? Medcan’s director of clinical innovation, Allison Hazell, investigates with the help of Dr. Lewis Roberts, director of the Mayo Clinic’s Hepatobiliary Cancer Lab.

Check out the episode webpage for links and more info.

  continue reading

104 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide